Facebook
Twitter
LinkedIn
ForwardRecent Courses
| Title | Credit | Start and expiration dates | Member price |
Non-member price |
|---|---|---|---|---|
| Integrating Genetics and Genomics into Practice |
|
05/14/2018 to 05/31/2020 | $10.00 | $20.00 |
| The Limping Child and Various Other Orthopedic Complaints 2018 |
|
12/31/2018 to 12/31/2020 | $10.00 | $20.00 |
| Case Study: ADHD - Part 3: DBP Clinic: Treatment Approaches, Psychopharmacology Treatments |
|
04/11/2019 to 04/30/2020 | $10.00 | $20.00 |
| Pediatric Primary Care Headache Evaluation |
|
05/16/2019 to 06/30/2021 | $10.00 | $20.00 |
| 2017 Pediatric RX, Module 5: Nutraceutical and Supplement Use in Children |
|
10/01/2017 to 09/30/2019 | $10.00 | $20.00 |
Pages
Pending Activities
Transcript
More NAPNAP CE Courses!
PedsCESM News:
Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention - Medscape Education and NAPNAP
NAPNAP’s newest online CE course, Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention, features two of our members Deena Garner, DNP, APRN CPNP-PC and Alison Moriarty Daley, PhD, APRN, PPCNP-BC, FAAN, and will improve clinicians' knowledge and competence regarding human papillomavirus (HPV) vaccination recommendations and strategies for advocating for vaccination and improving vaccine uptake. This FREE CE activity offers 0.5 NAPNAP contact hours (0.5 Rx) and is available now!
Clinical Insights in Pediatrics: Juvenile Idiopathic Arthritis: Diagnosis and Management in Primary Care - cmecorner.com
This activity offered by cmecorner.com discusses the most common inflammatory arthritis in the pediatric population. Over 300,000 children and adolescents are affected by JIA in the USA.The management of JIA represents a significant challenge to physicians, NPs, and other clinicians, particularly those in front-line specialties such as pediatrics and primary care. This activity will address timely diagnosis/classification of JIA and appropriate treatment, which are critical for preventing joint damage and improving long-term outcomes. Approved for 0.75 NAPNAP Contact Hour of which 0.25 contain pharmacology content. (Expires September 14, 2019).